Psychemedics Corporation Appoints William Norris as Controller of the Company, Effective as of January 1, 2023
December 30, 2022 at 04:30 pm EST
Share
On December 30, 2022, the Psychemedics Corporation (the Company) appointed William Norris as Controller of
the Company, to take effect as of January 1, 2023. In such capacity Mr. Norris, age 34, will serve as the
Company's principal financial and accounting officer, and will be responsible for all internal and external
financial reporting activities, as well as the Company's financial analysis and planning activities. Mr. Norris has over 10 years of finance and accounting experience. Most recently, he served as Assistant Controller for the Company since August 2022 and as Accounting Manager for the Company from April 2021 until August 2022. From February 2020 until April 2021, he served as a Senior Accountant at Vicinity Energy, a clean energy company that owns and operates a portfolio of district energy systems. From 2016 to 2019, he served as an external auditor at Warren Averett, a public accounting firm. He received his bachelor's degree in Accounting from Birmingham-Southern College, his MBA from Boston University, and is a Certified Public Accountant.
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
PSYCHEMEDICS CORPORATION 
